Buchner Matthias, Neubauer Eva, Zahlten-Hinguranage Anita, Schiltenwolf Marcus
Clinic of Orthopaedic Surgery, University of Heidelberg, Schlierbacher Landstrasse 200a, 69118, Heidelberg, Germany.
Clin Rheumatol. 2007 Mar;26(3):385-92. doi: 10.1007/s10067-006-0368-1. Epub 2006 Jul 25.
This prospective longitudinal clinical study evaluates the prognostic value of age in the therapy outcome of patients with chronic low back pain treated with a multidisciplinary therapy. Four hundred five patients with chronic low back pain for 3 months or longer and a corresponding sick leave for longer than 6 weeks underwent a 3-week standardized multidisciplinary therapy. Patients were assigned into three groups of age with comparable baseline values at T0. At the 6-month follow-up (T1) five different therapy outcomes were analysed and compared in the three groups: back-to-work status, generic health status (SF36), pain intensity, functional capacity, and satisfaction with the therapy. All three treatment groups improved significantly in all outcome criteria between T0 and T1 except of functional capacity, which did not improve in the older patients. In the total group, the back-to-work rate was 61.7%. At the final follow-up, there were significantly better results in terms of functional capacity and pain level in younger patients, whereas back-to-work rate and satisfaction with therapy did not show a significant difference between the groups analysed. According to the results of this study, older patients with chronic low back pain also derive significant benefit from a multidisciplinary treatment strategy, although in some outcome criteria results were inferior to those obtained in younger patients.
这项前瞻性纵向临床研究评估了年龄在多学科治疗慢性下腰痛患者治疗结果中的预后价值。405例慢性下腰痛3个月或更长时间且相应病假超过6周的患者接受了为期3周的标准化多学科治疗。患者按年龄分为三组,在T0时基线值具有可比性。在6个月随访(T1)时,分析并比较了三组的五种不同治疗结果:重返工作状态、一般健康状况(SF36)、疼痛强度、功能能力和对治疗的满意度。除功能能力外,所有三个治疗组在T0和T1之间的所有结果标准上均有显著改善,老年患者的功能能力未得到改善。在整个组中,重返工作率为61.7%。在最终随访时,年轻患者在功能能力和疼痛水平方面的结果明显更好,而分析的各组之间重返工作率和对治疗的满意度没有显著差异。根据这项研究的结果,慢性下腰痛的老年患者也能从多学科治疗策略中获得显著益处,尽管在某些结果标准上,结果不如年轻患者。